Novartis Institutes-Bio Med entered the industry of Research Institute in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 6215110, which describes it as a Research Institute. For further clarification, the SIC classifies this business under the code 8733 and described it as a Research Institute. The business provides service to the B2B market.
To acquire more information, please contact Mark Fishman by calling (617) 871-8000 during business hours. You can also write to the business’ Single Location at 250 Massachusetts Avenue, Cambridge, Massachusetts MA 02139. You can also visit the company’s website at nibr.novartis.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Novartis Institutes-Bio Med |
| Representative: | Mark Fishman |
| Place of Business: | 250 Massachusetts Avenue, Cambridge, MA 02139 |
| Contact Number: | (617) 871-8000 |
| Website: | nibr.novartis.com |
| Type of Service: | Research Institute |
| SIC Number: | 8733 |
| NAICS Number: | 6215110 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2002 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Novartis Institutes-Bio Med is a company operating from Middlesex, Massachusetts providing professional Research Institute and relevant B2B variables. It was founded in 2002 and registered with the SIC code 8733 as Research Institute, and with the NAICS code 6215110 as Research Institute.
With a current employee count of 1 to 4, Novartis Institutes-Bio Med has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Mark Fishman at (617) 871-8000 for related queries, or to locate its Single Location using the coordinates 42.36158,-71.0974.
The Single Location can also be found at the street address 250 Massachusetts Avenue in Cambridge, Massachusetts 02139 and can be engaged online through the company website at nibr.novartis.com, the company Twitter , and Facebook page .